Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Other Non Operating Income (2021 - 2025)

Beauty Health (SKIN) has disclosed Other Non Operating Income for 5 consecutive years, with $124000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 102.77% to $124000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 million through Dec 2025, up 203.33% year-over-year, with the annual reading at $18.9 million for FY2025, 508.17% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $124000.0 at Beauty Health, down from $601000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $4.9 million in Q3 2023, with the low at -$4.5 million in Q4 2024.
  • Average Other Non Operating Income over 5 years is $362526.3, with a median of $69000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income soared 3712.5% in 2022, then plummeted 2534.04% in 2024.
  • Over 5 years, Other Non Operating Income stood at $4.2 million in 2021, then tumbled by 121.7% to -$916000.0 in 2022, then tumbled by 222.27% to -$3.0 million in 2023, then crashed by 51.56% to -$4.5 million in 2024, then soared by 102.77% to $124000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $124000.0, $601000.0, and $4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.